Heron Therapeutics, Inc. (HRTX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 34.71M | 40.59M | 38.21M | 37.2M | 38.9M | 40.78M | 32.81M | 36.02M | 34.67M | 34.23M | 31.43M | 31.76M | 29.61M | 30.03M | 26.56M | 27.63M | 23.46M | 20.66M | 23.23M | 22.44M |
| Revenue Growth % | -10.78% | -0.47% | 16.47% | 3.26% | 12.21% | 19.13% | 4.38% | 13.42% | 17.07% | 14% | 18.36% | 14.95% | 26.25% | 45.38% | 14.32% | 23.11% | 17.18% | 0.24% | 16.35% | -0.99% |
| Cost of Goods Sold | 10.64M | 7.65M | 15.38M | 9.86M | 8.46M | 10.23M | 9.46M | 10.52M | 8.44M | 9.88M | 18.21M | 20.16M | 16.85M | 12.63M | 14.72M | 16.18M | 11.36M | 10.94M | 11.35M | 14.52M |
| COGS % of Revenue | 30.65% | 18.85% | 40.26% | 26.5% | 21.74% | 25.08% | 28.83% | 29.2% | 24.36% | 28.88% | 57.92% | 63.47% | 56.91% | 42.05% | 55.42% | 58.54% | 48.41% | 52.97% | 48.86% | 64.71% |
| Gross Profit | 24.07M | 32.94M | 22.83M | 27.34M | 30.45M | 30.55M | 23.35M | 25.51M | 26.23M | 24.35M | 13.23M | 11.6M | 12.76M | 17.4M | 11.84M | 11.46M | 12.1M | 9.71M | 11.88M | 7.92M |
| Gross Margin % | 69.35% | 81.15% | 59.74% | 73.5% | 78.26% | 74.92% | 71.17% | 70.8% | 75.64% | 71.12% | 42.08% | 36.53% | 43.09% | 57.95% | 44.58% | 41.46% | 51.59% | 47.03% | 51.14% | 35.29% |
| Gross Profit Growth % | -20.93% | 7.81% | -2.24% | 7.2% | 16.09% | 25.48% | 76.56% | 119.8% | 105.52% | 39.92% | 11.71% | 1.3% | 5.45% | 79.13% | -0.33% | 44.62% | 11.94% | -13.37% | -7.16% | -42.03% |
| Operating Expenses | 28.84M | 32.9M | 26.92M | 28.98M | 27.29M | 26.38M | 27.81M | 31.95M | 31.02M | 34.57M | 38.16M | 54.01M | 45.82M | 37.76M | 53.72M | 60.95M | 75.03M | 63.25M | 63.59M | 68.39M |
| OpEx % of Revenue | 83.08% | 81.06% | 70.45% | 77.9% | 70.15% | 64.69% | 84.76% | 88.69% | 89.48% | 100.98% | 121.38% | 170.04% | 154.73% | 125.74% | 202.29% | 220.6% | 319.84% | 306.23% | 273.73% | 304.73% |
| Selling, General & Admin | 26.45M | 25.68M | 26.92M | 26.05M | 25.01M | 23.2M | 23.34M | 27.52M | 26.42M | 23.62M | 24.6M | 40.8M | 36.99M | 26.7M | 28.18M | 32.12M | 32.95M | 34.37M | 34.99M | 33.16M |
| SG&A % of Revenue | 76.21% | 63.28% | 70.45% | 70.02% | 64.3% | 56.89% | 71.15% | 76.39% | 76.19% | 68.99% | 78.25% | 128.45% | 124.9% | 88.91% | 106.1% | 116.25% | 140.49% | 166.42% | 150.63% | 147.74% |
| Research & Development | 2.38M | 3.75M | 3.47M | 2.93M | 2.28M | 3.18M | 4.46M | 4.43M | 4.61M | 10.95M | 13.56M | 13.21M | 8.84M | 11.06M | 25.55M | 28.83M | 42.07M | 28.88M | 28.59M | 35.23M |
| R&D % of Revenue | 6.87% | 9.23% | 9.08% | 7.89% | 5.86% | 7.79% | 13.61% | 12.3% | 13.29% | 31.99% | 43.13% | 41.59% | 29.84% | 36.82% | 96.19% | 104.36% | 179.35% | 139.81% | 123.1% | 156.99% |
| Other Operating Expenses | 0 | 1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.76M | 38K | -4.09M | -1.64M | 3.15M | 4.17M | -4.46M | -6.45M | -4.8M | -10.22M | -24.93M | -42.4M | -33.06M | -20.36M | -41.88M | -49.5M | -62.92M | -53.54M | -51.71M | -60.47M |
| Operating Margin % | -13.73% | 0.09% | -10.71% | -4.4% | 8.11% | 10.23% | -13.59% | -17.89% | -13.84% | -29.85% | -79.31% | -133.5% | -111.64% | -67.79% | -157.71% | -179.15% | -268.25% | -259.2% | -222.59% | -269.43% |
| Operating Income Growth % | -251.08% | -99.09% | 8.19% | 74.6% | 165.74% | 140.83% | 82.12% | 84.8% | 85.49% | 49.79% | 40.48% | 14.33% | 47.45% | 61.98% | 19% | 18.14% | -20.74% | 12.66% | 11.43% | -8.47% |
| EBITDA | -4.76M | 1.2M | -3.48M | -1.03M | 3.71M | 4.75M | -3.88M | -5.8M | -4.11M | -9.51M | -24.2M | -41.66M | -32.34M | -19.56M | -41.18M | -48.83M | -62.2M | -52.74M | -50.95M | -59.73M |
| EBITDA Margin % | -13.73% | 2.96% | -9.1% | -2.76% | 9.52% | 11.66% | -11.82% | -16.11% | -11.85% | -27.77% | -76.99% | -131.18% | -109.22% | -65.15% | -155.05% | -176.72% | -265.17% | -255.35% | -219.35% | -266.16% |
| EBITDA Growth % | -228.61% | -74.76% | 10.29% | 82.32% | 190.17% | 150.02% | 83.98% | 86.07% | 87.3% | 51.42% | 41.22% | 14.67% | 48% | 62.91% | 19.19% | 18.26% | -21.07% | 12.94% | 11.56% | -8.6% |
| D&A (Non-Cash Add-back) | 0 | 1.16M | 615K | 611K | 551K | 581K | 581K | 641K | 689K | 715K | 727K | 739K | 718K | 791K | 706K | 671K | 721K | 794K | 754K | 734K |
| EBIT | -4.76M | -1.95M | -14.6M | -1.64M | 3.15M | 8.15M | -4.46M | -6.45M | -4.8M | -6.3M | -24.93M | -42.4M | -33.06M | -25.25M | -41.88M | -49.5M | -62.92M | -53.98M | -51.71M | -60.47M |
| Net Interest Income | 0 | -1M | -2.9M | 0 | -500K | -4.43M | -500K | -400K | -563K | -32K | -563K | 0 | 0 | -836K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.14M | 0 | 0 | 0 | 1.64M | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 1M | 2.9M | 0 | 500K | 4.43M | 500K | 400K | 563K | 2.17M | 563K | 0 | 0 | 2.47M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.35M | -2.99M | -13.4M | -744K | -519K | -510K | -390K | -2.79M | 1.64M | -504K | -79K | 344K | 295K | 486K | -26K | -6.86M | -965K | -1.11M | -700K | -546K |
| Pretax Income | -8.11M | -2.95M | -17.5M | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.77M | -19.87M | -41.91M | -56.36M | -63.89M | -54.65M | -52.41M | -61.02M |
| Pretax Margin % | -23.37% | -7.28% | -45.78% | -6.4% | 6.77% | 8.98% | -14.78% | -25.64% | -9.11% | -31.33% | -79.56% | -132.42% | -110.65% | -66.17% | -157.8% | -203.98% | -272.36% | -264.57% | -225.6% | -271.87% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -8.11M | -2.95M | -17.5M | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.77M | -19.87M | -41.91M | -56.36M | -63.89M | -54.65M | -52.41M | -61.02M |
| Net Margin % | -23.37% | -7.28% | -45.78% | -6.4% | 6.77% | 8.98% | -14.78% | -25.64% | -9.11% | -31.33% | -79.56% | -132.42% | -110.65% | -66.17% | -157.8% | -203.98% | -272.36% | -264.57% | -225.6% | -271.87% |
| Net Income Growth % | -407.82% | -180.64% | -260.87% | 74.22% | 183.39% | 134.16% | 80.61% | 78.04% | 90.36% | 46.03% | 40.33% | 25.37% | 48.71% | 63.64% | 20.04% | 7.63% | -21.43% | 12.26% | 10% | -10.55% |
| Net Income (Continuing) | -8.11M | -2.95M | -17.5M | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.77M | -19.87M | -41.91M | -56.36M | -63.89M | -54.65M | -52.41M | -61.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.23 | -0.38 | -0.55 | -0.63 | -0.54 | -0.51 | -0.62 |
| EPS Growth % | -300% | -183.68% | -215.46% | 67% | 195.69% | 133.47% | 81.35% | 82.69% | 92.26% | 68.96% | 55.26% | 36.36% | 57.14% | 57.41% | 25.49% | 11.29% | -8.62% | 20.59% | 20.31% | -1.64% |
| EPS (Basic) | -0.04 | -0.02 | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 | -0.06 | -0.02 | -0.07 | -0.17 | -0.35 | -0.27 | -0.23 | -0.38 | -0.55 | -0.63 | -0.54 | -0.51 | -0.62 |
| Diluted Shares Outstanding | 189.65M | 166.71M | 170.35M | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M |
| Basic Shares Outstanding | 189.65M | 166.71M | 170.35M | 154.02M | 153.49M | 153.15M | 152.83M | 152.31M | 151.2M | 150.28M | 144.99M | 119.72M | 119.25M | 119.16M | 111.73M | 102.41M | 102.12M | 101.98M | 101.91M | 98.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |